Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Diagnostic yield of repeat testing for SARS-CoV-2: Experience from a large health system in Los Angeles

International Journal of Infectious Diseases(2020)10.1016/j.ijid.2020.08.048Source: DataRank Database

Diagnostic yield of repeat testing for SARS-CoV-2: Experience from a large health system in Los Angeles is a dataset published in International Journal of Infectious Diseases (2020). On theSindex it has a DataRank of 0.796, placing it in the top 25.3% of the data-sharing corpus. It has been cited 8 times, with 8 citing works in its 1-hop citation network.

Top 25%percentile

0.796DataRank

Ranks in the top 25% for downstream scientific impact

Data paper Open Access8 citations · 8 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (67)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (1/3)

Dataset classification

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 41%Citation Network 59%

Base Score Contribution

0.330

From this paper's citation signal

Citation Network Contribution

0.467

From 6 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 8 citers.

Clinical yield of multiple testing with respiratory pathogen panels
Diagnostic Microbiology and Infectious Disease20214 citations8 referencesContributes 0.201
Self-quarantine programme and pre-operative SARS-CoV-2 PCR screening for orthopaedic elective surgery: experience from Japan
International Orthopaedics20218 citations22 referencesContributes 0.100
Provision of safe patient care during the COVID-19 pandemic despite shared patient rooms in a tertiary hospital
Antimicrobial Resistance and Infection Control20227 citations24 referencesContributes 0.087
The Health and Social Needs of Patients Discharged From the Emergency Department With Suspected COVID-19
Public Health Reports20215 citations21 referencesContributes 0.085
“Test and Standard Precautions”—Is It Enough to Protect Us From False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Test Results?
Anesthesia & Analgesia20202 citations25 referencesContributes 0.044

Authors (5)

David Goodman‐Meza ORCID,Tara Vijayan ORCID,Shangxin Yang ORCID,Omai B. Garner ORCID,Paul C. Adamson ORCID

Live enrichment

PubMed:32835787 PMC:PMC7441934

National Institutes of Health

Grant: K08DA048163

National Institutes of Health

Grant: T32MH080634

National Institutes of Health

Grant: 5T32MH080634-04

Postdoctoral Training in Global AIDS Prevention Research

National Institutes of Health

Grant: 5K08DA048163-02

Using data science to measure the impact of opioid agonist therapy in patients admitted with Staphylococcus aureus bloodstream infections

goldLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.ijid.2020.08.048

publisherhttps://api.elsevier.com/content/article/PII:S1201971220306780?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1201971220306780?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7441934

repositoryhttps://doaj.org/article/e8e2e07b754b4ea4a179ab2411bc3643

Fields of Study

0302 clinical medicine03 medical and health sciences

MeSH Terms

HumansRetrospective StudiesReproducibility of ResultsHealth PersonnelLos AngelesPandemicsCOVID-19SARS-CoV-2COVID-19 Testing

Keywords

DiagnosisDiagnostic TestingCovid-19Sars-cov-2Sars-cov-2 Rt-pcr1117 Public Health and Health Services (for)CoronavirusesEpidemiologyInfectious and parasitic diseasesRC109-216COVID-19 Testing0605 Microbiology (for)Reproducibility of Results (mesh)32 Biomedical and Clinical Sciences (for-2020)42 Health Sciences (for-2020)Public healthHumans (mesh)3 Good Health and Well Being (sdg)COVID-19 (mesh)General MedicineLos AngelesInfectious DiseasesMedical Microbiology4.2 Evaluation of markers and technologies (hrcs-rac)Public Health and Health Services4.2 Evaluation of markers and technologiesMicrobiology (medical)Retrospective Studies (mesh)Health PersonnelClinical Sciences610SARS-CoV-2 (mesh)MicrobiologyEmerging Infectious Diseases (rcdc)ArticleLos Angeles (mesh)COVID-19 Testing (mesh)Health SciencesHumansPandemics3202 Clinical Sciences (for-2020)Retrospective StudiesBiomedical and Clinical SciencesPandemics (mesh)4.1 Discovery and preclinical testing of markers and technologies (hrcs-rac)1108 Medical Microbiology (for)Coronaviruses (rcdc)Reproducibility of ResultsHealth Personnel (mesh)4.1 Discovery and preclinical testing of markers and technologiesEmerging Infectious DiseasesGood Health and Well Being4206 Public health (for-2020)Infectious Diseases (rcdc)Microbiology (science-metrix)4202 Epidemiology (for-2020)

Sustainable Development Goals

SDG 3: 3. Good health